Modification of biochemical recurrence risk in patients with localized prostate cancer after radical prostatectomy with combined histomorphological changes in the peritumoral zone
- Authors: Bova FS1, Kit OI2, Maksimov AY.2, Karnaukhov NS2
-
Affiliations:
- Regional Hospital №2
- Rostov Research Institute of Oncology
- Issue: Vol 99, No 3 (2018)
- Pages: 408-415
- Section: Theoretical and clinical medicine
- URL: https://journal-vniispk.ru/kazanmedj/article/view/8892
- DOI: https://doi.org/10.17816/KMJ2018-408
- ID: 8892
Cite item
Full Text
Abstract
Aim. To assess the prognostic significance of histopathological processes in the peritumoral zone with respect to the risk of biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.
Methods. Histomorphological studies were conducted in the perifocal area of surgical tissue samples from 309 patients with localized prostate cancer (T1c-2cN0M0) after a radical surgery using light microscopy. Four groups of patients were identified depending on the risk of recurrence. Enzyme immunoassay was used to determine the concentration of prostate-specific antigen in the serum at baseline and every 3 months for two years after the surgery to detect biochemical recurrence.
Results. Histomorphological examination of the peritumoral zone made it possible to identify histopathological processes associated with adenocarcinoma in 257 out of 309 (83.2%) patients with localized prostate cancer. The risk of biochemical recurrence of a combination of prostatic adenocarcinoma and prostatic intraepithelial neoplasia-2 increased by 3.3 (p=0.02), and of a combination of adenocarcinoma, neoplasia and chronic inflammation in the perifocal zone increased by 4.5 times (p=0.005) compared to patients without histopathological changes of the peritumoral zone. In combination of prostate adenocarcinoma with neoplasia and chronic inflammation in the peritumoral zone, the number of patients with an intermediate risk of cancer recurrence after surgical treatment increased due to decrease of the proportion of patients with very low and low risk of recurrence of the oncologic disease.
Conclusion. The combination of prostate cancer with high-grade prostatic intraepithelial neoplasia and chronic inflammation in the peritumoral zone modifies the risk of biochemical recurrence of cancer after radical prostatectomy.
Full Text
##article.viewOnOriginalSite##About the authors
F S Bova
Regional Hospital №2
Author for correspondence.
Email: alald@inbox.ru
Rostov-on-Don, Russia
O I Kit
Rostov Research Institute of Oncology
Email: alald@inbox.ru
Rostov-on-Don, Russia
A Yu Maksimov
Rostov Research Institute of Oncology
Email: alald@inbox.ru
Rostov-on-Don, Russia
N S Karnaukhov
Rostov Research Institute of Oncology
Email: alald@inbox.ru
Rostov-on-Don, Russia
References
- Guliev F.A. Predictors of biochemical recurrence of prostate cancer. Kazan medical journal. 2017; 98 (6): 890–894. (In Russ.)
- Lozhkin E.A., Sukhanov S.A., Kir’yanov N.A. New criteria of morphological assessment of the prognosis of the prostate cancer. Ural'skiy meditsinskiy zhurnal. 2017; (4): 70–72. (In Russ.)
- Yurmazov Z.A. Place of PIN in tumor pathology of the prostate gland. Sibirskiy onkologicheskiy zhurnal. 2009; (suppl. 1): 224–225. (In Russ.)
- Bostwick D.G. Progression of prostatic intraepitelial neoplasia to early invasive adenocarcinoma. Eur. Urol. 1996; 30: 145–152. PMID: 8875195.
- Allina D.O., Andreeva Yu.Yu., Zavalishina L.E. et al. High-grade prostatic intraepithelial neoplasia: State-of-the-art. Arkhiv patologii. 2015; (1): 69–74. (In Russ.)
- Gorbunova E.N., Davydova D.A., Krupin V.N. Chronic inflammation and fibrosis as risk factors of the prostatic intraepithelial neoplasia and prostate cancer. Sovremennye tekhnologii v meditsine. 2011; (1): 79–83. (In Russ.)
- Yurmazov Z.A., Vasil'ev N.V. Clinical and morphological features of prostate cancer in combination with PIN. Sibirskiy onkologicheskiy zhurnal. 2010; (suppl. 1): 118. (In Russ.)
- Bova F.S., Kit O.I., Maksimov A.Yu., Dimitriadi S.N. The association of prostatic intraepithelial neoplasia of high degree in the peritumoral zone with recurrence after radical prostatectomy in patients with localized prostate cancer. Prakticheskaya meditsina. 2017; (10): 108–112. (In Russ.)
- D'Amico A.V., Whittington R., Malkowicz S.B. et al. Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure. Urology. 1997; 49 (suppl. 3A): 23–30. doi: 10.1016/S0090-4295(97)00165-9.
- Dennis L.K., Lynch C.F., Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology. 2002; 60: 78–83. doi: 10.1016/S0090-4295(02)01637-0.
- Corn P.G. The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development. Cancer Manag. Res. 2012; 4: 183–193. doi: 10.2147/CMAR.S32839.
- Mc Neal J.E. Origin and development of carcinoma in the prostate. Cancer. 1969; 23: 24–34. doi: 10.1002/1097-0142(196901)23:1<24::AID-CNCR2820230103>3.0.CO;2-1.
- Platz E.A., Kulac I., Barber J., de Marzo A.M. A prospective study of chronic inflammation in benign prostate tissue and risk of prostate cancer: Linked PCPT and SELECT cohorts. Cancer Epidemiol. Biomarkers Prev. 2017; 26 (10): 1549–1557. doi: 10.1158/1055-9965.EPI-17-0503.
- Aliev M.D., Bohyan B.Yu., Burov D.A. Prognostic role of margin resection in surgery with soft tissue sarcomas. Prakticheskaya onkologiya. 2013; 14 (2): 97–100. (In Russ.)
Supplementary files
